In α1AT deficiency, pathological mutants induce the formation of polymers that accumulate at the site of production in the liver [9], with a concomitant depletion of circulating monomeric α1AT levels in the plasma [10]. Here, SERPINA1 is linked to hyperinsulinemic hypoglycemia, familial, 4.